Maximum binding assays with increasing numbers of cells (Figure S1B) showed immunoreactive fractions of 78.4% for 89Zr-hCD4-Mb using CD4-expressing human HPB-ALL cells and 84.3% for 89Zr-mCD4-Mb using murine CD4+ T cells. This evidence concerns the gene CD4 and acute lymphoblastic leukemia.